FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Astellas Pharma US Mycamine Recall

Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial Rx only Marketed by:…

Astellas Pharma US Inc · Northbrook, IL

Risk level
Class II
Reported by FDA
Feb 14, 2018
Recall ID
D-0548-2018
Check your lot numberHow we source this data

Summary

Astellas Pharma US recalled Mycamine starting Jan 22, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0548-2018 on Feb 14, 2018. Reason: Labeling: Label Error on Declared Strength. Status: Terminated.

Why it was recalled

Labeling: Label Error on Declared Strength

Product description

Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial Rx only Marketed by: Astellas Pharma US, Inc. Northbrook, IL 60062, NDC 0469-3211-10

Lot numbers, UPCs & expiration codes

Lots: F1700164 Exp. 02/20; A000000220 Exp. 06/20

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0548-2018
Classification
Class II
Status
Terminated
Recall initiated
Jan 22, 2018
FDA report date
Feb 14, 2018
Quantity
63600 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Astellas Pharma US Inc

Original FDA data

Every field from FDA enforcement report D-0548-2018, exactly as published.

Show all FDA fields
City
Northbrook
State
IL
Status
Terminated
Country
United States
Event ID
78981
Address
1 Astellas Way
Code information
Lots: F1700164 Exp. 02/20; A000000220 Exp. 06/20
Postal code
60062-6111
Report date
Feb 14, 2018
Product type
Drugs
Recall number
D-0548-2018
Classification
Class II
Recalling firm
Astellas Pharma US Inc
Product quantity
63600 vials
Termination date
May 1, 2019
Reason for recall
Labeling: Label Error on Declared Strength
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial Rx only Marketed by: Astellas Pharma US, Inc. Northbrook, IL 60062, NDC 0469-3211-10
Distribution pattern
Nationwide.
Recall initiation date
Jan 22, 2018
Initial firm notification
Letter
Center classification date
Feb 27, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0548-2018, published Feb 14, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls